Literature DB >> 22790567

Astaxanthin enhances ATP-binding cassette transporter A1/G1 expressions and cholesterol efflux from macrophages.

Maki Iizuka1, Makoto Ayaori, Harumi Uto-Kondo, Emi Yakushiji, Shunichi Takiguchi, Kazuhiro Nakaya, Tetsuya Hisada, Makoto Sasaki, Tomohiro Komatsu, Makiko Yogo, Yoshimi Kishimoto, Kazuo Kondo, Katsunori Ikewaki.   

Abstract

ATP-binding cassette transporters (ABC) A1 and G1 are key molecules in cholesterol efflux from macrophages, which is an initial step of reverse cholesterol transport (RCT), a major anti-atherogenic property of high-density lipoprotein (HDL). Astaxanthin is one of the naturally occurring carotenoids responsible for the pink-red pigmentation in a variety of living organisms. Although astaxanthin is known to be a strong antioxidant, it remains unclear through what mechanism of action it affects cholesterol homeostasis in macrophages. We therefore investigated the effects of astaxanthin on cholesterol efflux and ABCA1/G1 expressions in macrophages. Astaxanthin enhanced both apolipoprotein (apo) A-I- and HDL-mediated cholesterol efflux from RAW264.7 cells. In supporting these enhanced cholesterol efflux mechanisms, astaxanthin promoted ABCA1/G1 expression in various macrophages. In contrast, peroxisome proliferator-activated receptor γ, liver X receptor (LXR) α and LXRβ levels remained unchanged by astaxanthin. An experiment using actinomycin D demonstrated that astaxanthin transcriptionally induced ABCA1/G1 expression, and oxysterol depletion caused by overexpression of cholesterol sulfotransferase further revealed that these inductions in ABCA1/G1 were independent of LXR-mediated pathways. Finally, we performed luciferase assays using human ABCA1/G1 promoter-reporter constructs to reveal that astaxanthin activated both promoters irrespective of the presence or absence of LXR-responsive elements, indicating LXR-independence of these activations. In conclusion, astaxanthin increased ABCA1/G1 expression, thereby enhancing apoA-I/HDL-mediated cholesterol efflux from the macrophages in an LXR-independent manner. In addition to the anti-oxidative properties, the potential cardioprotective properties of astaxanthin might therefore be associated with an enhanced anti-atherogenic function of HDL.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22790567     DOI: 10.3177/jnsv.58.96

Source DB:  PubMed          Journal:  J Nutr Sci Vitaminol (Tokyo)        ISSN: 0301-4800            Impact factor:   2.000


  13 in total

1.  The inhibition of macrophage foam cell formation by 9-cis β-carotene is driven by BCMO1 activity.

Authors:  Noa Zolberg Relevy; Sapir Bechor; Ayelet Harari; Ami Ben-Amotz; Yehuda Kamari; Dror Harats; Aviv Shaish
Journal:  PLoS One       Date:  2015-01-28       Impact factor: 3.240

Review 2.  Lipid profile and glucose changes after supplementation with astaxanthin: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Sorin Ursoniu; Amirhossein Sahebkar; Maria-Corina Serban; Maciej Banach
Journal:  Arch Med Sci       Date:  2015-04-23       Impact factor: 3.318

Review 3.  Astaxanthin: sources, extraction, stability, biological activities and its commercial applications--a review.

Authors:  Ranga Rao Ambati; Siew Moi Phang; Sarada Ravi; Ravishankar Gokare Aswathanarayana
Journal:  Mar Drugs       Date:  2014-01-07       Impact factor: 5.118

Review 4.  Potential Anti-Atherosclerotic Properties of Astaxanthin.

Authors:  Yoshimi Kishimoto; Hiroshi Yoshida; Kazuo Kondo
Journal:  Mar Drugs       Date:  2016-02-05       Impact factor: 5.118

5.  Effects of Astaxanthin on Reverse Cholesterol Transport and Atherosclerosis in Mice.

Authors:  Tang-Bin Zou; Shan-Shan Zhu; Fei Luo; Wei-Qiao Li; Xue-Rong Sun; Hong-Fu Wu
Journal:  Biomed Res Int       Date:  2017-11-01       Impact factor: 3.411

6.  The Forty-Sixth Euro Congress on Drug Synthesis and Analysis: Snapshot .

Authors:  Pavel Mucaji; Atanas G Atanasov; Andrzej Bak; Violetta Kozik; Karolina Sieron; Mark Olsen; Weidong Pan; Yazhou Liu; Shengchao Hu; Junjie Lan; Norbert Haider; Robert Musiol; Jan Vanco; Marc Diederich; Seungwon Ji; Jan Zitko; Dongdong Wang; Danica Agbaba; Katarina Nikolic; Slavica Oljacic; Jelica Vucicevic; Daniela Jezova; Anna Tsantili-Kakoulidou; Fotios Tsopelas; Constantinos Giaginis; Teresa Kowalska; Mieczyslaw Sajewicz; Jerzy Silberring; Przemyslaw Mielczarek; Marek Smoluch; Izabela Jendrzejewska; Jaroslaw Polanski; Josef Jampilek
Journal:  Molecules       Date:  2017-10-28       Impact factor: 4.411

7.  Plasma levels of HDL and carotenoids are lower in dementia patients with vascular comorbidities.

Authors:  Irundika H K Dias; Maria Cristina Polidori; Li Li; Daniela Weber; Wilhelm Stahl; Gereon Nelles; Tilman Grune; Helen R Griffiths
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

8.  9-cis β-Carotene Increased Cholesterol Efflux to HDL in Macrophages.

Authors:  Sapir Bechor; Noa Zolberg Relevy; Ayelet Harari; Tal Almog; Yehuda Kamari; Ami Ben-Amotz; Dror Harats; Aviv Shaish
Journal:  Nutrients       Date:  2016-07-19       Impact factor: 5.717

Review 9.  Bioaccessibility of Marine Carotenoids.

Authors:  Isabel Viera; Antonio Pérez-Gálvez; María Roca
Journal:  Mar Drugs       Date:  2018-10-22       Impact factor: 5.118

Review 10.  ABCA1, apoA-I, and BTN3A1: A Legitimate Ménage à Trois in Dendritic Cells.

Authors:  Chiara Riganti; Barbara Castella; Massimo Massaia
Journal:  Front Immunol       Date:  2018-06-08       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.